Valuation: Henan Lingrui Pharmaceutical Co., Ltd.

Market Cap 13.7B 2.05B 1.87B 1.73B 1.57B 2.94B 192B 3.07B 20.92B 8.3B 104B 7.7B 7.54B 328B P/E 2026 *
16.5x
P/E 2027 * 15.3x
Enterprise Value 13.58B 2.03B 1.85B 1.72B 1.55B 2.91B 190B 3.05B 20.74B 8.23B 103B 7.63B 7.47B 325B EV / Sales 2026 *
3.37x
EV / Sales 2027 * 3.08x
Free-Float
75.98%
Yield 2026 *
5.03%
Yield 2027 * 5.23%
1 day+0.17%
1 week+7.14%
Current month+9.77%
1 month+14.67%
3 months+22.40%
6 months+10.93%
Current year+16.61%
1 week 22.17
Extreme 22.17
24.45
1 month 19.68
Extreme 19.68
24.45
Current year 18.51
Extreme 18.51
24.45
1 year 18.51
Extreme 18.51
24.45
3 years 16.07
Extreme 16.07
27.26
5 years 10
Extreme 10
27.26
10 years 6.81
Extreme 6.81
27.26
Manager TitleAgeSince
Chief Executive Officer 42 06/06/2014
Director of Finance/CFO 57 06/06/2020
Corporate Officer/Principal 54 08/06/2011
Director TitleAgeSince
Director/Board Member 57 -
Chairman 42 29/04/2019
Director/Board Member 37 06/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
10/01/25 Buy 150,000 0.0265%
10/01/25 Buy 150,000 0.0265%
10/01/25 Buy

Director

150,000 0.0265%
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%+7.14%+8.49%+41.06% 2.05B
-2.25%-5.30%+28.78%+126.18% 1,232B
-2.04%-5.78%+31.91%+78.20% 656B
-0.90%-3.74%+21.70%+104.93% 506B
-1.04%-0.67%+30.16%+68.01% 382B
-3.67%-9.68%+39.63%+29.26% 340B
-3.22%-4.14%+24.75%+51.30% 294B
-2.51%-4.26%-1.93%+29.67% 278B
-1.14%-6.05%+28.16%+65.37% 240B
-1.45%-0.85%+30.03%+119.12% 210B
Average -1.69%-1.46%+24.17%+71.31% 414B
Weighted average by Cap. -1.78%-2.67%+27.10%+86.92%

Financials

2026 *2027 *
Net sales 4.03B 604M 551M 510M 461M 865M 56.45B 905M 6.16B 2.44B 30.5B 2.27B 2.22B 96.63B 4.36B 654M 595M 551M 499M 935M 61.04B 979M 6.66B 2.64B 32.98B 2.45B 2.4B 104B
Net income 829M 124M 113M 105M 94.79M 178M 11.6B 186M 1.27B 502M 6.27B 466M 456M 19.86B 894M 134M 122M 113M 102M 192M 12.51B 201M 1.37B 542M 6.76B 502M 492M 21.41B
Net Debt -120M -18.02M -16.42M -15.2M -13.75M -25.79M -1.68B -26.99M -184M -72.86M -909M -67.59M -66.18M -2.88B -266M -39.87M -36.32M -33.62M -30.41M -57.06M -3.72B -59.72M -406M -161M -2.01B -150M -146M -6.37B
Projected Income Statement - Annual - Henan Lingrui Pharmaceutical Co., Ltd.
Logo Henan Lingrui Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company operates its businesses through two segments. The Pharmaceutical and Health Care segment is mainly engaged in the production and sales of plasters, oral medicines and ointments. The Other segment is mainly engaged in hotel, catering services and others. The Company's main products include Tongluo Qutong Cream, Huoxue Xiaotong Tincture, Zhuanggu Shexiang Pain Relief Cream, Peiyuan Tongnao Capsules, Shenqi Jiangtang Capsules and others. The Company mainly operates its businesses in the domestic market.
Employees
2,789
Date Price Change Volume
19/11/26 CN¥24.15 +0.17% 8,243,525
18/11/26 CN¥24.11 +0.46% 11,412,284
17/11/26 CN¥24.00 +2.43% 16,401,199
16/11/26 CN¥23.43 +2.94% 14,204,608
13/11/26 CN¥22.76 +1.61% 12,272,529
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Henan Lingrui Pharmaceutical Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
24.15CNY
Average target price
26.20CNY
Spread / Average Target
+8.49%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Henan Lingrui Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 600285 Stock